EU clears Aptus' endostapling system for AAA
Aptus Endosystems, a developer of endovascular aneurysm repair technologies, has received CE mark approval for the Aptus EndoStapling System, a helical staple technology that enables independent endograft fixation, and is designed to mimic the hand suturing performed during open surgical repair of abdominal aortic aneurysms (AAAs).
In EVAR, an alternative to open surgical repair, a metal and fabric endograft is implanted using a catheter-based delivery system to isolate blood flow away from the aneurysm to prevent potential rupture and death.
According to the Sunnyvale, Calif.-based company, the EndoStapling System provides physicians with a technology to repair endovascular grafts that have exhibited migration or endoleaks (or are at risk of these complications which are commonly seen after EVAR) where augmented radial fixation and/or sealing is required to regain or maintain effective aortic aneurysm exclusion. The system also can be used during de novo EVAR procedures (at the time of initial endograft implantation) to enhance an endograft’s inherent fixation and sealing mechanisms.
In EVAR, an alternative to open surgical repair, a metal and fabric endograft is implanted using a catheter-based delivery system to isolate blood flow away from the aneurysm to prevent potential rupture and death.
According to the Sunnyvale, Calif.-based company, the EndoStapling System provides physicians with a technology to repair endovascular grafts that have exhibited migration or endoleaks (or are at risk of these complications which are commonly seen after EVAR) where augmented radial fixation and/or sealing is required to regain or maintain effective aortic aneurysm exclusion. The system also can be used during de novo EVAR procedures (at the time of initial endograft implantation) to enhance an endograft’s inherent fixation and sealing mechanisms.